Compound details
Tyrosol
| Compound ID | CDAMM02100 |
|---|---|
| Common name | Tyrosol | IUPAC name | 4-(2-hydroxyethyl)phenol |
| Molecular formula | C8H10O2 |
| Retention time | 8.6 |
|---|---|
| Adduct | [M+NH4]+ |
| Actual mz | 156.101 | Theoretical mz | 156.102 |
| Error | 2.71 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.8407 |
| Inchi key | YCCILVSKPBXVIP-UHFFFAOYSA-N |
|---|---|
| Smiles | OC1=CC=C(C=C1)CCO |
| Superclass | Benzenoids |
| Class | Phenols |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction and SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SEA |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SEA |
| Q96RJ0 | TAAR1 | Trace amine-associated receptor 1 (by homology) | T99524 | SEA |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SEA |
| P03372 | ESR1 | Estrogen receptor alpha | T02506 | SEA |
| P42858 | HTT | Huntingtin | T22496 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| Q9GZQ4 | NMUR2 | Neuromedin-U receptor 2 | T04210 | SEA |
| P62508 | ESRRG | Estrogen-related receptor gamma | T59875 | SEA |
| Q9Y345 | SLC6A5 | Glycine transporter 2 | T58937 | SEA |
| P09172 | DBH | Dopamine beta hydroxylase | T74937 | SEA |
| Q96HK3 | CALM | Calmodulin | T39610 | SEA |
| O14804 | TAAR5 | Trace amine receptor 5 | T60362 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T99524 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q96RJ0 | TAAR1 |
| T99524 | DI0149 | Focal/segmental autonomic disorder | [ICD-11: 8D8A] | Q96RJ0 | TAAR1 |
| T99524 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q96RJ0 | TAAR1 |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T02506 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P03372 | ESR1 |
| T22496 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | P42858 | HTT |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T74937 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P09172 | DBH |
| T74937 | DI0341 | Post-traumatic stress disorder | [ICD-11: 6B40] | P09172 | DBH |
| T39610 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | Q96HK3 | CALM |
| T39610 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q96HK3 | CALM |
| T39610 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q96HK3 | CALM |